Island Pharmaceuticals
Island Pharmaceuticals is focused on drug repurposing and clinical development for viral diseases lacking existing therapies. Their business model centers around identifying and developing solutions for unmet medical needs in the treatment of viral infections. The company aims to create value by advancing repurposed drug candidates through clinical trials and ultimately to market.
Short position
Island Pharmaceuticals (ASX:ILA) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 4 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.19% in March 2023. ILA is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Island Pharmaceuticals (ILA) Short Interest
Island Pharmaceuticals (ASX:ILA) had 0.00% of shares reported as short positions as of 5 Oct 2026, representing 4 shares. Island Pharmaceuticals operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads ILA today
- Zanger BreakoutNot a candidate
- CAN SLIMNot a candidate
- Minervini Trend TemplateNot a candidate
- Crowded-Short BreakoutNot a candidate
- Quality compoundersNot a candidate
Prices to 9 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
ILA fundamentals
In the year to 30 Jun 2026, Island Pharmaceuticals (ASX:ILA) recorded revenue of A$282.7K and a net loss after tax of A$9.8M. Net margin −3,482.7% (FY). Figures are in AUD, the company's reporting currency; source: Yahoo Finance, as at 29 Sep 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest ILA news
All news- Island Pharmaceuticals Grants 500,000 Unquoted Options to Consultants at $0.55 Exercise Price
kalkine · 9 Oct 2026
- Notification regarding unquoted securities - ILA
asx · 8 Oct 2026
- Island Pharma’s FDA Animal Rule route to big vouchers, bigger contracts
stockhead · 7 Oct 2026
About
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss ILA
Start a research thread or post the first pulse update